Company / EPS (Basic)
ORAMED PHARMACEUTICALS INC. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.48
FY2025
5-year range
-$0.94 / $0.78
FY2022-FY2025
Trend
-442.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) changed -443% YoY in FY2025, a notable deviation from the 3-year average annual change of -183%.
Based on SEC 10-K filings.
-0.48 in FY2025.
Improved from $-0.94 to $-0.48 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) decreased 442.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.48 | -442.9% |
| FY2024 | $0.14 | +114.9% |
| FY2023 | -$0.94 | -220.5% |
| FY2022 | $0.78 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026